Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/150908COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies |
Autor: | Hellner, Karin; Mota, Alba CSIC ORCID; Moreno-Bueno, Gema CSIC ORCID; Matías-Guiu, Xavier; Benítez, Javier; Ashour Ahmed, Ahmed | Palabras clave: | Precancer Fallopian tube BRCA mutations SOX2 Screening Ovarian cancer |
Fecha de publicación: | 2016 | Editor: | Elsevier | Citación: | EBioMedicine 10: 137-149 (2016) | Resumen: | Current screening methods for ovarian cancer can only detect advanced disease. Earlier detection has proved difficult because the molecular precursors involved in the natural history of the disease are unknown. To identify early driver mutations in ovarian cancer cells, we used dense whole genome sequencing of micrometastases and microscopic residual disease collected at three time points over three years from a single patient during treatment for high-grade serous ovarian cancer (HGSOC). The functional and clinical significance of the identified mutations was examined using a combination of population-based whole genome sequencing, targeted deep sequencing, multi-center analysis of protein expression, loss of function experiments in an in-vivo reporter assay and mammalian models, and gain of function experiments in primary cultured fallopian tube epithelial (FTE) cells. We identified frequent mutations involving a 40kb distal repressor region for the key stem cell differentiation gene SOX2. In the apparently normal FTE, the region was also mutated. This was associated with a profound increase in SOX2 expression (p<2(-16)), which was not found in patients without cancer (n=108). Importantly, we show that SOX2 overexpression in FTE is nearly ubiquitous in patients with HGSOCs (n=100), and common in BRCA1-BRCA2 mutation carriers (n=71) who underwent prophylactic salpingo-oophorectomy. We propose that the finding of SOX2 overexpression in FTE could be exploited to develop biomarkers for detecting disease at a premalignant stage, which would reduce mortality from this devastating disease. | Descripción: | Open Access funded by Medical Research Council. Under a Creative Commons license.-- et al. | Versión del editor: | https://doi.org/10.1016/j.ebiom.2016.06.048 | URI: | http://hdl.handle.net/10261/150908 | DOI: | 10.1016/j.ebiom.2016.06.048 | Identificadores: | doi: 10.1016/j.ebiom.2016.06.048 e-issn: 2352-3964 |
| Aparece en las colecciones: | (IIBM) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| PremalignantSOX2.pdf | 1,56 MB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
22
checked on 25-abr-2024
SCOPUSTM
Citations
30
checked on 23-abr-2024
WEB OF SCIENCETM
Citations
29
checked on 25-feb-2024
Page view(s)
301
checked on 24-abr-2024
Download(s)
332
checked on 24-abr-2024
